Literature DB >> 18327562

[Medical therapy of urinary tract infection].

G Stein1, R Fünfstück.   

Abstract

Urinary tract infections (UTI) are the most common bacterial infectious diseases seen in the community, in most cases caused by E. coli. The treatment strategy differs depending on localization (lower vs. upper UT), acute uncomplicated vs. complicated infection, as well as for chronic disease and asymptomatic bacteriuria, the known or susceptible causative uropathogen with the (local) resistance pattern and the morbidity of the patient. There is a considerable worrying increase in the resistance rate of E. coli to TMP/SMX, quinolones and others. Most patients with uncomplicated, in the community acquired UTI are treated safely and effectively as out-patients. The available data support a short-course therapy with 3 days as the current standard therapy for lower UTI, but with a 7-14 days treatment for upper and complicated UTI. Recurrent UTI is best managed by low-dose antimicrobial prophylaxis for 3-6 (12 ore more) months. Besides that, new approaches to preventive strategies must prove their value in specific patient groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18327562     DOI: 10.1007/s00108-008-2036-9

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  21 in total

Review 1.  [Recurrent urinary tract infections in women. Virulence of pathogens and host reaction].

Authors:  T Oelschlaeger; R Fünfstück
Journal:  Urologe A       Date:  2006-04       Impact factor: 0.639

2.  Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial.

Authors:  A Stapleton; R H Latham; C Johnson; W E Stamm
Journal:  JAMA       Date:  1990-08-08       Impact factor: 56.272

3.  Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.

Authors:  Marcus D Säemann; Thomas Weichhart; Maximilian Zeyda; Günther Staffler; Michael Schunn; Karl M Stuhlmeier; Yuri Sobanov; Thomas M Stulnig; Shizuo Akira; Alexander von Gabain; Uwe von Ahsen; Walter H Hörl; Gerhard J Zlabinger
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  Urinalysis predictive of urine culture results.

Authors:  B L Bailey
Journal:  J Fam Pract       Date:  1995-01       Impact factor: 0.493

Review 5.  Cranberries for preventing urinary tract infections.

Authors:  R G Jepson; L Mihaljevic; J Craig
Journal:  Cochrane Database Syst Rev       Date:  2000

6.  The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study.

Authors:  Sven A Ferry; Stig E Holm; Hans Stenlund; Rolf Lundholm; Tor J Monsen
Journal:  Scand J Infect Dis       Date:  2004

7.  Risk factors for urinary tract infections in postmenopausal women.

Authors:  Kent K Hu; Edward J Boyko; Delia Scholes; Esther Normand; Chi-Ling Chen; Jane Grafton; Stephan D Fihn
Journal:  Arch Intern Med       Date:  2004-05-10

8.  Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women.

Authors:  A Aune; T Alraek; H LiHua; A Baerheim
Journal:  Scand J Prim Health Care       Date:  1998-03       Impact factor: 2.581

Review 9.  Modes of administration of antibiotics for symptomatic severe urinary tract infections.

Authors:  A Pohl
Journal:  Cochrane Database Syst Rev       Date:  2007-10-17

10.  Cross-resistance and associated resistance in 2478 Escherichia coli isolates from the Pan-European ECO.SENS Project surveying the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections.

Authors:  Gunnar Kahlmeter; Paul Menday
Journal:  J Antimicrob Chemother       Date:  2003-06-12       Impact factor: 5.790

View more
  1 in total

Review 1.  [Urinary tract infections].

Authors:  W H Hörl
Journal:  Internist (Berl)       Date:  2011-09       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.